Thinking of joining a study?

Register your interest

NCT06148077 | RECRUITING | Head and Neck Cancer


Manual Therapy for Oropharyngeal Function and Upper Quarter Mobility on Head and Neck Cancer Survivors
Sponsor:

University of La Frontera

Information provided by (Responsible Party):

Barbara Burgos Mansilla

Brief Summary:

Trismus has been reported as the second most common comorbidity in survivors of head and neck cancer (HNC). It is mainly associated with post-radiotherapy subcutaneous fibrosis, muscular atrophy, damage to neurological structures in the neck, or a combination of all, affecting masticatory musculature. In addition to this, the loss of flexibility and strength in the shoulder has also been shown to be related to deficits in the function and quality of life of these patients. The goal of this clinical trial is to determinate the effectiveness and safety of Manual Therapy (MT) on Oropharyngeal Function, as well as the mobility of the upper quarter, the strength of cervical musculature, pain, functionality, and the perception of quality of life in head and neck cancer survivors. Participants will be assigned randomly to the study groups: a) manual therapy program and control motor exercises and b) motor control exercises (usual care). The assessment refers to a baseline form (at the beginning of the study), at 6 weeks and at 6 weeks of patient follow-up.

Condition or disease

Head and Neck Cancer

Trismus

Dysfunction

Intervention/treatment

Manual Therapy

Motor control exercises

Phase

NA

Detailed Description:

Manual therapy program consists of 3 sessions a week during 6 weeks, with a total of 18 appointments. Measurements are done before starting, after the last intervention and 6 weeks after finishing the treatment.

Study Type : INTERVENTIONAL
Estimated Enrollment : 36 participants
Masking : DOUBLE
Primary Purpose : TREATMENT
Official Title : Effects of Manual Therapy on Oropharyngeal Function and Upper Quarter Mobility in Survivors of Head and Neck Cancer: a Randomized, Controlled Pilot Trial
Actual Study Start Date : 2024-09-25
Estimated Primary Completion Date : 2025-10-01
Estimated Study Completion Date : 2025-10-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * individuals with HNC
  • * individuals over 18 years of age
  • * individuals who have undergone oncological surgery of the head and neck and/or radiotherapy
  • * having finished oncological medical treatment between 3 and 36 months before inclusion
  • * having a medical diagnosis of trismus and/or TMD and/or cervical or shoulder dysfunction
Exclusion Criteria
  • * sequelae of previous stroke
  • * structural instability and/or osteoporosis of the cervical spine, spondylosis, cervical herniated discs
  • * active osteoradionecrosis or open wounds (fistulas, soft tissue necrosis) in the anatomical treatment area
  • * tracheostomized individuals
  • * metastasis or active cancer
  • * refuse to participate.

Manual Therapy for Oropharyngeal Function and Upper Quarter Mobility on Head and Neck Cancer Survivors

Location Details

NCT06148077


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

Chile, Cautín

Barbara Burgos Mansilla

Temuco, I am looking for, Chile,

RECRUITING

Chile, Cautín

University of La Frontera

Temuco, I am looking for, Chile,

Loading...